Tumor Necrosis Factor (Tnf) Protects Resistant C57bl/6 Mice Against Herpes Simplex Virus-induced Encephalitis Independently of Signaling Via Tnf Receptor 1 or 2.
From: City of Hope Medical Center and Beckman Research Institute, Department of Virology, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
Journal of virology
- Publish Date: Feb 2007
- ISSN: 0022-538X
- Volume: 81
- Issue: 3
- Pages: 1451-60
- Medium: Print
- Language: English
- Citation (JAMA): Lundberg Patric, Welander Paula V, Edwards Carl K, et al. Tumor Necrosis Factor (Tnf) Protects Resistant C57bl/6 Mice Against Herpes Simplex Virus-induced Encephalitis Independently of Signaling Via Tnf Receptor 1 or 2.. J. Virol. Feb 2007;81:1451-60
Abstract
Tumor necrosis factor (TNF) is a multifunctional cytokine that has a role in induction and regulation of host innate and adaptive immune responses. The importance of TNF antiviral mechanisms is reflected by the diverse strategies adopted by different viruses, particularly members of the herpesvirus family, to block TNF responses. TNF binds and signals through two receptors, Tnfrsf1a (TNF receptor 1 [TNFR1], or p55) and Tnfrsf1b (TNFR2, or p75). We report here that herpes simplex virus 1 (HSV-1) infection of TNF-/- mice on the resistant C57BL/6 genetic background results in significantly increased susceptibility (P < 0.0001, log rank test) to fatal HSV encephalitis (HSE) and prolonged persistence of elevated levels of virus in neural tissues. In contrast, although virus titers in neural tissues of p55-/- N13 mice were elevated to levels comparable to what was found for the TNF-/- mice, the p55-/- N13 mice were as resistant as control C57BL/6 mice (P > 0.05). The incidence of fatal HSE was significantly increased by in vivo neutralization of TNF using soluble TNFR1 (sTNFR1) or depletion of macrophages in C57BL/6 mice (P = 0.0038 and P = 0.0071, respectively). Strikingly, in vivo neutralization of TNF in HSV-1-infected p55-/- p75-/- mice by use of three independent approaches (treatment with soluble p55 receptor, anti-TNF monoclonal antibody, or in vivo small interfering RNA against TNF) resulted in significantly increased mortality rates (P = 0.005), comparable in magnitude to those for C57BL/6 mice treated with sTNFR1 (P = 0.0018). Overall, these results indicate that while TNF is required for resistance to fatal HSE, both p55 and p75 receptors are dispensable. Precisely how TNF mediates protection against HSV-1 mortality in p55-/- p75-/- mice remains to be determined.
Mesh Headings (Keywords): Animals, Antiviral Agents, Encephalitis, Herpes Simplex, Mice, Mice, Inbred C57BL, Receptors, Tumor Necrosis Factor, Signal Transduction, Simplexvirus, Tumor Necrosis Factor-alpha
Check for Full Text / PubMed Unique Identifier (PMID): 17108044
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.